2025-08-08 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the data provided.

## Colgate-Palmolive Co (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive is a global consumer products company focused on oral care, personal care, home care, and pet nutrition.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 10.68%
*   **VOO Cumulative Return:** 82.59%
*   **Deviation:** -83.9
*   **Relative Deviation:** 4.3

**Analysis:** Colgate-Palmolive (CL) has significantly underperformed the S&P 500 (VOO) based on cumulative returns.  The deviation of -83.9 indicates a substantial performance gap. A relative deviation of 4.3 suggests that CL is at the lower end of its historical performance range relative to the S&P 500.

### 2. Alpha, Beta Analysis

Here's a breakdown of the Alpha and Beta metrics for CL over different periods:

| Year       | CAGR     | MDD     | Alpha   | Beta   | Cap(B) |
|------------|----------|---------|---------|--------|--------|
| 2015-2017  | 3.0%     | 0.0%    | 0.0%    | -0.2   | 61.0   |
| 2016-2018  | -16.0%   | 65.2%   | -11.0%  | -0.1   | 48.1   |
| 2017-2019  | -2.0%    | 65.2%   | -25.0%  | -0.0   | 55.6   |
| 2018-2020  | 20.0%    | 65.2%   | -7.0%   | 0.0    | 69.1   |
| 2019-2021  | 30.0%    | 58.6%   | -19.0%  | 0.2    | 69.0   |
| 2020-2022  | 8.0%     | 69.0%   | 2.0%    | 0.2    | 63.7   |
| 2021-2023  | 7.0%     | 69.0%   | -13.0%  | 0.9    | 64.4   |
| 2022-2024  | 14.0%    | 69.0%   | -13.0%  | 0.9    | 73.5   |
| 2023-2025  | 1.0%     | 70.6%   | -47.0%  | 0.3    | 68.5   |

**Analysis:**

*   **Alpha:**  The consistently negative Alpha values (except for 2020-2022) suggest that CL has generally underperformed its expected return based on its risk profile. This underperformance is especially pronounced recently.
*   **Beta:** Beta values fluctuate but are generally low, indicating that CL's price is not very sensitive to overall market movements (S&P 500).  Beta has increased in recent periods (2021-2024), suggesting a slightly higher correlation with the market.
*   **CAGR:** Compounded Average Growth Rate shows inconsistent growth, with negative periods mixed with positive ones. The most recent period (2023-2025) shows minimal growth.
*   **MDD:** Maximum Drawdown is high, indicating significant potential losses from peak to trough during the observed periods.

### 3. Recent Price Action

*   **Current Price:** 84.71
*   **Previous Close:** 84.61
*   **Change:** 0.12
*   **5-day Moving Average:** 83.85
*   **20-day Moving Average:** 86.552
*   **60-day Moving Average:** 89.3015

**Analysis:**

*   The price change between the current price and the previous close indicates a slight upward movement, but this increase is not particularly significant.
*   The 5-day moving average is below the current price, suggesting a short-term upward trend.
*   The current price is below both the 20-day and 60-day moving averages, indicating a potential longer-term downward trend.

### 4. Technical Indicators

*   **MRI:** 0.3318 (Low Risk)
*   **RSI:** 39.87
*   **PPO:** -0.2754
*   **Hybrid Signal:** Cash_70%_Sell 69.9% of holdings (1144 shares - Caution - MRI:0.34) (Cash Ratio: 70% on 2025-07-16)
*   **Recent (20-day) Relative Deviation Change:** 4.3 (+) - short term increase
*   **Expected Return (%):** -857.6%

**Analysis:**

*   **MRI:** The Market Risk Indicator is in the "Low Risk" range, suggesting a relatively stable market environment for this stock.
*   **RSI:** The Relative Strength Index (RSI) of 39.87 is below 50, nearing oversold territory, potentially indicating a buying opportunity.
*   **PPO:** The Percentage Price Oscillator (PPO) is negative (-0.2754), suggesting a downward trend.
*   **Hybrid Signal:**  The signal recommends reducing holdings to a 70% cash position, reflecting caution given the MRI level.
*   **Recent Relative Deviation Change:** A positive change in relative deviation suggests a short-term improvement compared to the S&P 500.
*   **Expected Return:** The extremely negative expected return suggests significant underperformance is anticipated compared to the S&P 500 over the long term.

### 5. Recent News & Significant Events

*   **2025-08-04:** Business developments, regulatory changes, or market events.
*   **2025-08-07:** Analyst discussions on performance and outlook.
*   **2025-08-06:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-08-05:** Expert advice to monitor recent news and company announcements.

**Analysis:**  Recent news indicates potential volatility and important developments affecting CL.  Investors should monitor company announcements and analyst reports closely.

### 6. Recent Earnings Analysis

| Date       | EPS  | Revenue |
|------------|------|---------|
| 2025-08-01 | 0.92 | 5.11 B$ |
| 2025-04-25 | 0.85 | 4.91 B$ |
| 2024-10-25 | 0.9  | 5.03 B$ |
| 2024-07-26 | 0.89 | 5.06 B$ |
| 2025-08-01 | 0.89 | 5.06 B$ |

**Analysis:**

*   EPS (Earnings Per Share) has fluctuated slightly, with the latest value at 0.92.
*   Revenue shows some variation but has generally remained in the $4.9B to $5.1B range.

### 7. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $5.11B  | 60.06%        |
| 2025-03-31 | $4.91B  | 60.82%        |
| 2024-12-31 | $4.95B  | 60.30%        |
| 2024-09-30 | $5.03B  | 61.08%        |
| 2024-06-30 | $5.06B  | 60.62%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-06-30 | $0.70B   | 105.84%    |
| 2025-03-31 | $0.36B   | 190.08%    |
| 2024-12-31 | $0.21B   | 348.58%    |
| 2024-09-30 | $0.43B   | 169.43%    |
| 2024-06-30 | $0.12B   | 594.31%    |

**Analysis:**

*   **Revenue:** Revenue has remained relatively stable.
*   **Profit Margin:** Profit margins are consistently high, indicating strong profitability.
*   **Equity:** Equity has fluctuated.
*   **ROE:** Return on Equity (ROE) is very high but highly volatile.

### 8. Overall Analysis

Colgate-Palmolive (CL) exhibits a mixed picture:

*   **Underperformance:**  It has significantly underperformed the S&P 500 based on historical returns and future expected returns.
*   **Low Market Sensitivity:**  The low Beta suggests its price is less sensitive to overall market movements.
*   **High Profitability:** High profit margins demonstrate the company's efficiency. However, Return On Equity (ROE) is very high but volatile.
*   **Caution Advised:** Technical indicators and hybrid signals suggest a cautious approach.
*   **Important to Monitor:** Recent news and events indicate potential near-term volatility.

**Conclusion:** While Colgate-Palmolive demonstrates stability and high profitability, its underperformance relative to the market and cautious technical indicators suggest investors should proceed with caution and closely monitor news and company announcements. The extremely negative expected return is a significant concern.
